Adcetris 50 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBN1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,868
Award facts
- Contract value 100% obligated
- $82,867.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $82,867.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Adcetris 50 mg vials. The award, issued on November 25, 2025, with an ultimate completion date of December 17, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors. The parent IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036.
Under the PPV-G GEN V framework, DMS Pharmaceutical Group is authorized to supply a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, over-the-counter drugs, and medical consumables to support Department of Defense healthcare operations globally. The delivery of Adcetris, an oncology treatment, reflects the contractor's established capability to fulfill specialized pharmaceutical requirements for military medical facilities. DMS Pharmaceutical Group's registration in the System for Award Management since 2001 and its demonstrated performance across numerous delivery orders position it as a critical supplier within the federal pharmaceutical supply chain serving military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FFBN1?
SPE2DR26FFBN1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FFBN1 worth?
The government has obligated $82,868 on SPE2DR26FFBN1.
Is contract SPE2DR26FFBN1 an order under another contract?
Yes. SPE2DR26FFBN1 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBN1 competed?
The extent of competition for SPE2DR26FFBN1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award